Jesse Haramati

Anti-fouling SERS-based immunosensor for point-of-care detection of the B7–H6 tumor biomarker in cervical cancer patient serum

Sandeep Surendra Panikar, Nehla Banu, Jesse Haramati et al. · Analytica Chimica Acta · 2020 · 56 citations

Biomarker (Medicine), Oncology, Cervical Cancer +14

Differential effects of alliin and allicin on apoptosis and senescence in luminal A and triple‐negative breast cancer: Caspase, ΔΨm, and pro‐apoptotic gene involvement

Vida Celeste Rosas‐González, Martha Cecilia Téllez‐Bañuelos, Georgina Hernández‐Flores et al. · Fundamental and Clinical Pharmacology · 2020 · 42 citations

Immune checkpoint expression on peripheral cytotoxic lymphocytes in cervical cancer patients: moving beyond the PD-1/PD-L1 axis

Fabiola Solorzano‐Ibarra, Alan Guillermo Alejandre-González, Pablo Cesar Ortiz‐Lazareno et al. · Clinical & Experimental Immunology · 2020 · 23 citations · Full text

Loss of CD28 within CD4+ T cell subsets from cervical cancer patients is accompanied by the acquisition of intracellular perforin, and is further enhanced by NKG2D expression

Marta Escarra‐Senmarti, Miriam Ruth Bueno‐Topete, Luis Felipe Jave‐Suárez et al. · Immunology Letters · 2017 · 21 citations

Cancer Immunosurveillance, Cervical Cancer, Nkg2d Expression +8

Characterization of B7H6, an endogenous ligand for the NK cell activating receptor NKp30, reveals the identity of two different soluble isoforms during normal human pregnancy

Jorge Gutiérrez‐Franco, Rodolfo Hernández‐Gutiérrez, Miriam Ruth Bueno‐Topete et al. · Immunobiology · 2017 · 20 citations

Nk Cell, Lymphocyte Development, Immune Regulation +8